- Home
- MED vs SCPH Comparison
MED vs SCPH Comparison
Compare MED & SCPH Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- MED
- SCPH
- Stock Information
- Founded
- MED 1980
- SCPH 2013
- Country
- MED United States
- SCPH United States
- Employees
- MED N/A
- SCPH N/A
- Industry
- MED Packaged Foods
- SCPH Biotechnology: Pharmaceutical Preparations
- Sector
- MED Consumer Staples
- SCPH Health Care
- Exchange
- MED Nasdaq
- SCPH Nasdaq
- Market Cap
- MED 187.3M
- SCPH 160.6M
- IPO Year
- MED N/A
- SCPH 2017
- Fundamental
- Price
- MED $15.48
- SCPH $3.28
- Analyst Decision
- MED Hold
- SCPH Strong Buy
- Analyst Count
- MED 1
- SCPH 2
- Target Price
- MED $17.00
- SCPH $15.00
- AVG Volume (30 Days)
- MED 204.6K
- SCPH 251.3K
- Earning Date
- MED 02-18-2025
- SCPH 03-12-2025
- Dividend Yield
- MED N/A
- SCPH N/A
- EPS Growth
- MED N/A
- SCPH N/A
- EPS
- MED 0.67
- SCPH N/A
- Revenue
- MED $674,475,000.00
- SCPH $30,278,000.00
- Revenue This Year
- MED N/A
- SCPH $173.14
- Revenue Next Year
- MED N/A
- SCPH $131.01
- P/E Ratio
- MED $23.25
- SCPH N/A
- Revenue Growth
- MED N/A
- SCPH 303.87
- 52 Week Low
- MED $14.88
- SCPH $3.08
- 52 Week High
- MED $56.52
- SCPH $6.54
- Technical
- Relative Strength Index (RSI)
- MED 36.38
- SCPH 41.79
- Support Level
- MED $15.67
- SCPH $3.15
- Resistance Level
- MED $16.30
- SCPH $3.52
- Average True Range (ATR)
- MED 0.55
- SCPH 0.18
- MACD
- MED 0.09
- SCPH -0.00
- Stochastic Oscillator
- MED 25.16
- SCPH 15.22
About MED MEDIFAST INC
Medifast Inc is a United states based company that produces, distributes and sells products concerning weight loss, weight management, and healthy living. The company generates its revenue from point of sale transactions executed over an e-commerce platform for weight loss, weight management, and other consumable health and nutritional products.
About SCPH scPharmaceuticals Inc.
scPharmaceuticals Inc is a pharmaceutical company focused on developing and commercializing products that have the potential to optimize the delivery of infused therapies, advance patient care and reduce healthcare costs. The company's main product is Furoscix. Furoscix consists of this patented formulation of furosemide for subcutaneous administration with wearable, portable sc2Wear Infusor for the treatment of edema in patients with heart failure.